Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5000 participants.

Also called NCT04684602

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 5,000 participants (planned count) (from the registry)
Sponsor
Thomas Advanced Medical LLC (from the registry)
Registry
  • NCT NCT04684602
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04684602. Non-randomized; no masking; primary purpose treatment. Start 2020-07-09 (actual); primary completion 2030-07-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Condition
Autoimmune Diseases
Condition
Cardiovascular Disorders
Condition
Diabetes Complications
Condition
Integumentary Disease
Condition
Musculoskeletal Disorders
Condition
Neurodegenerative Disorders
Condition
Neurologic Disorders
Condition
Pulmonary Disorders
Condition
Sexual Dysfunction
Condition
Urologic Disorders
Condition
Viral Illness
Intervention (Biological)
PrimePro™/ PrimeMSK™
Lead sponsor
Thomas Advanced Medical LLC (class: industry)
Collaborator
HeartStem Institute (class: not stated)
Collaborator
NuStem (class: not stated)

Record details

Record id
cardio:ct-nct04684602
Content hash
3024a772a7ebfdd4019789e8db57050a6fd249946d5e83a55299e9c3eb53acde